120 related articles for article (PubMed ID: 29650905)
1. [A Case of HER2-Positive Breast Cancer with Liver Metastases Showing Three Years of Complete Response to Combination Therapy with Trastuzumabplus Pertuzumab].
Fujimoto Y; Yamaguchi K; Ueno A; Sakurai R; Nagahisa Y; Imai S; Kawamoto K
Gan To Kagaku Ryoho; 2018 Mar; 45(3):459-461. PubMed ID: 29650905
[TBL] [Abstract][Full Text] [Related]
2. [A Case of HER2-Positive Breast Cancer with Newly Diagnosed Stage IV That Responded to First-Line Pertuzumab and Trastuzumab-Based Therapy].
Yoshioka S; Hojo S; Toyoda Y; Maeura Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1214-1216. PubMed ID: 29394585
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Luminal-HER2 Advanced Breast Cancer with Liver Metastasis Showed Pathological Complete Response to the Therapy with Pertuzumab plus Trastuzumab plus Docetaxel].
Hamaoka A; Matsuda T; Konishi E; Taguchi T
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1097-100. PubMed ID: 27628551
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Long-Term Survival of Breast Cancer with Lymph Node and Liver Metastases Treated with Sequential Anti-HER2 Drugs, Chemotherapy, and Endocrine Therapy].
Katsumori T; Ohshima H; Hamaguchi H; Yamamoto S; Tsukamoto Y; Iwanaga T; Ohkawara S
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1838-1840. PubMed ID: 29394793
[TBL] [Abstract][Full Text] [Related]
5. [HER2-Positive T1a Breast Cancer Metastatic to the Liver and Brain in a Patient Who Died Four Years and Three Months after Mastectomy--A Case Report].
Takaoka A; Nakagawa T; Ogawa N; Hayashi M; Park S; Iseki H; Bei Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1779-81. PubMed ID: 26805170
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report].
Shigekawa T; Takeuchi H; Misumi M; Nakamiya N; Sugiyama M; Sugitani I; Fujiuchi N; Osaki A; Saeki T
Gan To Kagaku Ryoho; 2013 Feb; 40(2):225-7. PubMed ID: 23411960
[TBL] [Abstract][Full Text] [Related]
7. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
8. Complete pathologic response of HER2-positive breast cancer liver metastasis with dual anti-HER2 antagonism.
Schoellhammer HF; Hsu F; Vito C; Chu P; Park J; Waisman J; Kim J
BMC Cancer; 2014 Apr; 14():242. PubMed ID: 24708527
[TBL] [Abstract][Full Text] [Related]
9. [A Case of HER2-Positive Metastatic Breast Cancer Achieved a Complete Response to Paclitaxel and Trastuzumab in Combination with Pertuzumab in Fifth Therapy].
Mimata A; Yoshitomi S; Morikawa N; Hara K; Tsuji H
Gan To Kagaku Ryoho; 2021 Feb; 48(2):263-265. PubMed ID: 33597376
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab].
Ishida K
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1385-7. PubMed ID: 24196076
[TBL] [Abstract][Full Text] [Related]
11. A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
Inoue Y; Yamashita N; Tokunaga E; Tanaka K; Ueo H; Saeki H; Oki E; Yamamoto H; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1917-1921. PubMed ID: 28373460
[TBL] [Abstract][Full Text] [Related]
12. A case of metastatic breast cancer with outgrowth of HER2-negative cells after eradication of HER2-positive cells by humanized anti-HER2 monoclonal antibody (trastuzumab) combined with docetaxel.
Kunitomo K; Inoue S; Ichihara F; Kono K; Fujii H; Matsumoto Y; Ooi A
Hum Pathol; 2004 Mar; 35(3):379-81. PubMed ID: 15017597
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Gianni L; Pienkowski T; Im YH; Roman L; Tseng LM; Liu MC; Lluch A; Staroslawska E; de la Haba-Rodriguez J; Im SA; Pedrini JL; Poirier B; Morandi P; Semiglazov V; Srimuninnimit V; Bianchi G; Szado T; Ratnayake J; Ross G; Valagussa P
Lancet Oncol; 2012 Jan; 13(1):25-32. PubMed ID: 22153890
[TBL] [Abstract][Full Text] [Related]
14. [A long-term survival case of metastatic breast cancer treated with trastuzumab and paclitaxel].
Ogino T; Komoike Y; Ishitobi M; Motomura K; Inaji H; Koyama H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2234-6. PubMed ID: 19106581
[TBL] [Abstract][Full Text] [Related]
15. Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.
Morohashi S; Odagiri H; Morohashi H; Kimura Y; Sasaki M
Breast Cancer; 2007; 14(3):297-301. PubMed ID: 17690508
[TBL] [Abstract][Full Text] [Related]
16. Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.
Giotta F; Latorre A; Cramarossa A; Simone G; Florio C; Oliva S; Lorusso V
Tumori; 2013; 99(6):278e-81e. PubMed ID: 24503803
[TBL] [Abstract][Full Text] [Related]
17. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124
[TBL] [Abstract][Full Text] [Related]
18. Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.
Park JC; Ma TM; Rooper L; Hembrough T; Foss RD; Schmitt NC; Sawhney R; Flanders A; Kang H
Head Neck; 2018 Dec; 40(12):E100-E106. PubMed ID: 30478962
[TBL] [Abstract][Full Text] [Related]
19. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer.
Takada K; Kashiwagi S; Goto W; Asano Y; Morisaki T; Fujita H; Takashima T; Ohsawa M; Hirakawa K; Ohira M
Anticancer Res; 2018 Apr; 38(4):2285-2294. PubMed ID: 29599351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]